
OLD Category: signatures
January 2, 2020 / Nat Commun
Identification of recurrent FHL2-GLI2 oncogenic fusion in sclerosing stromal tumors of the ovary
January 1, 2020 / Methods Mol Biol
Development of Gene Expression-Based Biomarkers on the nCounter((R)) Platform for Immuno-Oncology Applications
January 1, 2020 / Methods Mol Biol
NanoString nCounter Technology: High-Throughput RNA Validation
January 1, 2020 / Curr Opin Oncol
Novel molecular targets for the treatment of lung cancer
January 1, 2020 / Brain Res.
Regulating PMP22 expression as a dosage sensitive neuropathy gene
January 1, 2020 / Clin Immunol.
Towards standardization of immune functional assays
January 1, 2020 / Methods Mol Biol
Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue
January 1, 2020 / Exerc Immunol Rev
Key viral immune genes and pathways identify elite athletes with URS
December 31, 2019 / Exp Neurobiol